Patents.WorldPatents.World
  • Patent Portfolios Home
  • About us
  • Contact us
0
  • Browse all
  • Litigation
  • Limestone Reports
    • Validity
    • Patentability
    • Landscape
    • Classification
  • Free Portfolios
  • Private Portfolios
  • Launch Carly – PBA
  • Login / Register
HomeLitigationJANSSEN PRODUCTS, L.P. et al v. AMNEAL PHARMACEUTICALS, LLC et al

JANSSEN PRODUCTS, L.P. et al v. AMNEAL PHARMACEUTICALS, LLC et al

Litigation

Description

Description

This portfolio contains the entire content of each of the patents cited in this patent litigation case. You can download the portfolio as a single complete PDF file, for ease of viewing and sharing. Below is a summary/preview of what is in the PDF file.

Patents

US7126015B2 — Method for the preparation of hexahydro-furo-[2,3-b]furan-3-ol
US7595408B2 — Methods for the preparation of (3R,3aS,6aR) hexahydro-furo[2,3-b]furan-3-ol
US8518987B2 — Pseudopolymorphic forms of a HIV protease inhibitor

Classifications

C07D493/04Ortho-condensed systems
A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/18Antivirals for RNA viruses for HIV
A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
C07D307/20Oxygen atoms
A61P31/12Antivirals

Abstracts ( 3  of  3 )

The present invention relates to a method for the preparation of hexahydro-furo[2,3-b]furan-3-ol as well as novel intermediates for use in said method. More in particular the invention relates to a stereoselective method for the preparation of hexahydro-furo[2,3-b]furan-3-ol, and to a method amenable to industrial scaling up.

The present invention relates to methods for the preparation of diastereomerically pure (3R,3aS,6aR) hexahydro-furo[2,3-b]furan-3-ol as well as a novel intermediate, (3aR,4S,6aS) 4-methoxy-tetrahydro-furo[3,4-b]furan-2-one for use in said methods. More in particular the invention relates to a stereoselective method for the preparation of diastereomerically pure (3R,3aS,6aR) hexahydro-furo[2,3-b]furan-3-ol, as well as methods for the crystallization of (3aR,4S,6aS) 4-methoxy-tetrahydro-furo[3,4-b]furan-2-one and for the epimerization of (3aR,4R,6aS) 4-methoxy-tetrahydro-furo[3,4-b]-furan-2-one to (3aR,4S,6aS) 4-methoxy-tetrahydro-furo[3,4-b]furan-2-one.

New pseudopolymorphic forms of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate and processes for producing them are disclosed.

Reviews (0)

Only logged in customers who have purchased this product may leave a review.

Reviews

There are no reviews yet.

$ 10.00

Patent Litigation Case:  2:18-cv-17585
Filing Date:  12/26/2018

— OR —

Add to Bookmarks
Remove from Wishlist
Files Included
  • JANSSEN PRODUCTS, L.P. et al v. AMNEAL PHARMACEUTICALS, LLC et al

Warning: sizeof(): Parameter must be an array or an object that implements Countable in /home/customer/www/patents.world/public_html/wp-content/themes/wr-nitro/woocommerce/woorockets/single-product/style-5.php on line 185
Share this
Add to Bookmarks
Remove from Wishlist

Related Products

Quick ViewAdd to cart

Tela Innovations, Inc. v. Asustek Computer Inc. et al

Add to Bookmarks
Remove from Wishlist
$ 10.00
Quick ViewAdd to cart

Par Pharmaceutical, Inc. et al v. Amphastar Pharmaceuticals, Inc.

Add to Bookmarks
Remove from Wishlist
$ 10.00
Quick ViewAdd to cart

Wongab Corporation v. Saks Incorporated et al

Add to Bookmarks
Remove from Wishlist
$ 0.00
Quick ViewAdd to cart

Inventergy LBS, LLC v. Track What Matters, L.L.C.

Add to Bookmarks
Remove from Wishlist
$ 10.00
Footer logo

Quickly Buy or Create Downloadable Patent Portfolios

SITE INFO

  • About
  • Contact
  • Privacy Policy
  • Terms of Service
  • License Agreement

SHOP PORTFOLIOS

  • Litigation
  • Limestone Reports
  • Free Portfolios
  • Private Portfolios
  • Launch Carly – PBA

ACCOUNT INFO

  • My Account
  • Checkout
  • Bookmarked Portfolios
©2020 Patents.World. Made with ♥ in Austin, TX and Washington, DC
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok